161 related articles for article (PubMed ID: 17828445)
1. Enhanced oromucosal delivery of progesterone via hexosomes.
Swarnakar NK; Jain V; Dubey V; Mishra D; Jain NK
Pharm Res; 2007 Dec; 24(12):2223-30. PubMed ID: 17828445
[TBL] [Abstract][Full Text] [Related]
2. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
3. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
Mishra D; Garg M; Dubey V; Jain S; Jain NK
J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
[TBL] [Abstract][Full Text] [Related]
4. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
Dubey V; Mishra D; Jain NK
Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to enhance the mucoadhesion of lipid drug nanocarriers for improved drug delivery to the buccal mucosa.
Du JD; Liu Q; Salentinig S; Nguyen TH; Boyd BJ
Int J Pharm; 2014 Aug; 471(1-2):358-65. PubMed ID: 24879939
[TBL] [Abstract][Full Text] [Related]
6. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
[TBL] [Abstract][Full Text] [Related]
7. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approach.
Moghddam SM; Ahad A; Aqil M; Imam SS; Sultana Y
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):617-624. PubMed ID: 27050533
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.
Ge S; Lin Y; Lu H; Li Q; He J; Chen B; Wu C; Xu Y
Int J Pharm; 2014 Apr; 465(1-2):120-31. PubMed ID: 24530389
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
[TBL] [Abstract][Full Text] [Related]
10. The development of progesterone-loaded nanofibers using pressurized gyration: A novel approach to vaginal delivery for the prevention of pre-term birth.
Brako F; Raimi-Abraham BT; Mahalingam S; Craig DQM; Edirisinghe M
Int J Pharm; 2018 Apr; 540(1-2):31-39. PubMed ID: 29408268
[TBL] [Abstract][Full Text] [Related]
11. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
[TBL] [Abstract][Full Text] [Related]
12. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S
Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459
[TBL] [Abstract][Full Text] [Related]
13. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
14. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery.
El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND
Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196
[TBL] [Abstract][Full Text] [Related]
15. Design and development of a mucoadhesive buccal film bearing progesterone.
Jain SK; Jain A; Gupta Y; Kharya A
Pharmazie; 2008 Feb; 63(2):129-35. PubMed ID: 18380399
[TBL] [Abstract][Full Text] [Related]
16. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
[TBL] [Abstract][Full Text] [Related]
17. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.
Lopes LB; Ferreira DA; de Paula D; Garcia MT; Thomazini JA; Fantini MC; Bentley MV
Pharm Res; 2006 Jun; 23(6):1332-42. PubMed ID: 16715364
[TBL] [Abstract][Full Text] [Related]
18. Hexosomes formed from glycerate surfactants--formulation as a colloidal carrier for irinotecan.
Boyd BJ; Whittaker DV; Khoo SM; Davey G
Int J Pharm; 2006 Aug; 318(1-2):154-62. PubMed ID: 16621358
[TBL] [Abstract][Full Text] [Related]
19. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.
Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S
Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
